Background. The development of antiretroviral (ARV)-based prevention products has the potential to substantially change the HIV prevention landscape; yet, little is known about how appealing these products will be outside of clinical trials, as compared with the existing options. Methods. We conducted a discrete choice experiment (DCE) to measure preferences for 5 new products among 4 important populations in the HIV response: adult men and women in the general population (aged 18 to 49 y), adolescent girls (aged 16 to 17 y), and self-identifying female sex workers (aged 18 to 49 y). We interviewed 661 self-reported HIV-negative participants in peri-urban South Africa, who were asked to choose between 3 unique, hypothetical products over 10 choice sets. Data were analyzed using multinomial, latent class and mixed multinomial logit models. Results. HIV protection was the most important attribute to respondents; however, results indicate significant demand among all groups for multipurpose prevention products that offer protection from HIV infection, other STIs, and unwanted pregnancy. All groups demonstrated a strong preference for long-lasting injectable products. There was substantial heterogeneity in preferences within and across population groups. Limitations. Hypothetical DCE data may not mirror real-world choices, and products will have more attributes in reality than represented in choice tasks. Background data on participants, including sensitive areas of HIV status and condom use, was self-reported. Conclusions. These results suggest that stimulating demand for new HIV prevention products may require a more a nuanced approach than simply developing highly effective products. No single product is likely to be equally attractive or acceptable across different groups. This study strengthens the call for effective and attractive multipurpose prevention products to be deployed as part of a comprehensive combination prevention strategy.
identified to ensure that relevant products are made available to potential users. Even if only a small proportion of the population uses the products, they may still be costeffective if used consistently and effectively among those at risk of HIV acquisition. ARV-based pre-exposure prophylaxis (PrEP) offers varying degrees of protection to HIV-negative persons when delivered via daily or intermittent oral tablet, 6, 7 or a long-lasting intravaginal ring. 8, 9 However, product protection has been variable during clinical trials, as microbicide gels and vaginal rings confer substantially less protection to younger users than to older women primarily due to adherence issues. 8, 10 This is particularly concerning, as adolescent girls and young women (AGYW) face a far greater risk of HIV acquisition than older women, or men of any age. 3, 10 A promising field in HIV prevention is the development of multipurpose technologies (MPTs), products that simultaneously provide protection from 2 or more of HIV, other STIs, and unintended pregnancy. 11, 12 Current MPTs in development include 1) long-acting drug delivery systems, such as intravaginal rings designed to protect from HIV infection and pregnancy (currently in a phase-I trial, ClinicalTrials.gov Identifier: NCT02235662); 2) pericoital drug delivery systems, such as vaginal gesl, tablets and films designed to protect against HIV; and 3) a combination of products, such as a contraceptive diaphragms used with microbicide gels designed to protect from HIV, STIs, and pregnancy. 11, 13 Although MPT development is likely to be costly and complex, their benefits may also be large. First, products offering more than one indication may be more attractive to potential users than single-purpose products. Second, MPT use could crowd-in protection from lesser valued attributes. For example, where users value contraceptive properties more than they do HIV prevention, additional HIV protection would be a positive externality from the use of a dual-protective product. Third, the multipurpose nature of MPTs may reduce the stigma of accessing HIV prevention tools, which has been shown to be a substantive barrier to use, and prevent products from being perceived as only for certain populations. 14, 15 Accounting for the perspectives of end-users in product formulation and delivery could lead to more attractive products, greater uptake and adherence, and increased population protection. This study uses a discrete choice experiment (DCE) to elicit the preferences for 5 HIV prevention products (oral PrEP, a microbicide gel, a SILCS diaphragm used in concert with gel, an intravaginal ring, and an injectable) from 4 population groups (adult men and women aged 18 to 49 y, adolescent girls aged 16 to 17 y, and selfidentifying FSWs aged 18 to 49 y) in Vosloorus, a township in peri-urban Ekurhuleni, around 30 km from Johannesburg in the Gauteng province of South Africa. Because there are no observed data for many of these products, we gathered primary stated preference data using the DCE, an end-user focused approach to identifying key determinants of demand. 16, 17 DCEs ask respondents to choose their preferred product or service from a set of alternatives over a number (usually between 8 to 10) of choice tasks. By looking at how respondents choose across repeated scenarios, researchers can quantitatively elicit the key drivers of decision making. 18 Although men who have sex with men (MSM) are a high-risk group in South Africa, they were not purposively sampled in this study because 1) the contraceptive indication of interest would have little relevance among MSM practicing solely samesex intercourse; 2) the stigma associated with same-sex activity was considered to place interviewers or participants at risk, and 3) the number of MSM likely to be in the geographical location of the survey is small, coupled with the intensive resources required to reach adolescent and FSW groups. Where a small number of MSM were identified in the household survey, they were not excluded from data collection or analysis based on reported same-sex activity. The study was reviewed and approved by the University of the Witwatersrand Human Research Ethics Committee (M140614) and the Research Ethics Committee at the London School of Hygiene and Tropical Medicine (8541-2). All participation in the DCE and supporting qualitative studies was voluntary and subject to completion of a written informed consent process. Adolescent participants were asked for written assent, in addition to written consent provided by a parent or guardian per South African law. A comprehensive distress protocol adopted as standard study procedure ensured that participants who answered in the affirmative to questions about violence and/or other potentially distressing situations were referred to named persons at local clinics and NGOs for additional support.
Already popular in the health literature, 19 DCEs are increasingly applied in the HIV and sexual health fields. Previous work conducted in South Africa found HIV prevention efficacy to be a key driver of demand for a microbicide, a diaphragm, or a female condom. 20 A DCE was used to indicate that a rectal microbicide was acceptable among MSM in Thailand, with male sex workers more likely to use an efficacious product than other men. 21 A DCE in Tanzania showed that different population groups had markedly different preferences for HIV testing interventions among respondents who had been tested previously. 22 Two DCEs in Malawi found heterogeneity in the preferences of young people for HIV, sexual health, and family planning services. 23, 24 Finally, a conjoint analysis in 7 countries found PrEP to be broadly acceptable to potential end-users. 25 To our knowledge, this is the first study to explore how preferences for new HIV prevention products vary across general and key population groups, and provides important information on 1) preferences among different groups, 2) variation in preferences within groups, and 3) whether new products will be used alongside or instead of condoms. Such ''condom migration'' has been a concern in the design of PrEP programs and demonstration projects; yet, evidence is mixed as to whether condomless sex will increase after PrEP introduction.
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Methods
Study Context
Primary data collection was carried out in the town of Vosloorus, around 30 km south-east of Johannesburg, South Africa. Vosloorus contains a broad range of residential contexts representing a range of demographic, socioeconomic, and cultural characteristics. Formative research took place between August and September 2015, and the survey ran from October to December 2015. Further details on the study context and methods were published in the study protocol, 29 and no changes were made to the study design or analysis plan.
Development and Design of the Discrete Choice Experiment
The DCE was developed through an analysis of a previous DCE and focus-group discussions carried out in previous research, 18, 21 specifically identifying important characteristics of prevention products and exploring optimal ways to present these to participants in a clear and relatable manner. This was supplemented by a scoping literature review to identify new products and additional attributes that could be important to respondents, which was added to and refined through piloting. We opted to show 3 alternatives of new products in each task using an unlabeled design where each alternative represents a generic product within which all characteristics can change as prescribed by the statistical design. Although an unlabeled design (where each alternative represents a fixed product category) would have led to greater statistical efficiency, feedback from piloting was that a choice task with 5 labeled alternatives plus an opt-out was too complex. The opt-out alternative displayed characteristics of a male condom or non-protection, depending on what the respondent reported using in their last sex act.
The DCE was pre-piloted among 17 respondents from across the target populations. A separate design was generated for male and female groups, as men can only initiate use of 2 of the 5 potential products (the injectable and oral PrEP). The full survey and DCE was then piloted among 45 respondents from the target sampling frame. Few changes were made to the DCE after piloting, except to the side-effects attribute, where minor and frequent side-effect symptoms of nausea, stomach cramps, and dizziness were included over major, lessfrequent side-effects, such as reduction in bone mineral density or liver toxicity. This is a limitation of this study, but was necessary due to difficulties in participant comprehension of 1) varying probabilities of side-effects and 2) medical implications of more serious conditions in a brief DCE interview. Priors from an analysis of pilot data (n = 17) were used in NGENE software 30 to generate a single D-efficient design with 10 tasks, which avoided dominated or duplicated alternatives, as recommended. 31 A D-efficient design was chosen with the aim of improving precision in final model estimates while accounting for design constraints arising from restrictions on the frequency that the products could be used. The final 6 attributes of the DCE and their levels are shown in Table 1 , and Figure 1 shows an example of how choice tasks were presented to respondents who reported using a condom in their last sex-activity. For participants who reported not using a condom at their last sex-activity, the final column showed a ''nothing'' alternative, whilst male respondents saw identical sideeffects images but with male characters. The final design incorporated 10 choice tasks, with one additional task a repeat to check the consistency of responses.
Survey Methods
A household survey sampled adult men and women (aged 18 to 49 y), and adolescent girls (aged 16 to 17 y) randomly. Clusters of dwellings (census enumeration areas) within Ekurhuleni were selected at random using municipal data and aerial photographs, and interviewers contacted every second property after a random start. All eligible participants were interviewed within the selected households. The DCE and background survey was administered in English, Zulu, and Khosa languages using Open Data Kit (https://opendatakit.org) software on tablet computers, and participants were given ZAR 50 (GBP £2.50) vouchers as compensation for their time.
A team of 12 experienced interviewers from a specialist local data collection firm, Progressus Research and Development (http://www.progressus.co.za), implemented the survey.
FSWs are a hard to reach population, and we used respondent-driven sampling (RDS) to sample 203 active FSW participants. 32 Peer educators, most of whom were practicing sex workers, were used to locate 'hotspots' in Ekurhuleni. First, 12 were asked to act as 'seeds' to start RDS chains in different areas (i.e., women working in Because no product can be used at all frequencies, the design contained constraint terms where only relevant frequencies were presented alongside products. Frequencies were chosen to be informative for product development: Oral PrEP -Daily, weekly, monthly; Microbicide Gelcoitally; SILCS diaphragm and microbicide gel -coitally, daily; Vaginal ring -weekly, monthly, 3-monthly, 6-monthly; Injection -3-monthly, 6-monthly, annually. Figure 1 Example of discrete-choice experiment task as shown to females who used condoms at their last sex activity. brothels, hotels, or on the street). Seeds were invited to complete the survey and received the same ZAR 50 (GBP £2.50) compensation as participants in the general population. Women were then given 4 coupons containing study information to distribute to colleagues. When each referred colleague attended for an interview, their recruiter received a small incentive in the form of a ZAR 20 (GBP £1) voucher.
Choice Modeling
We modeled choices using random utility models, and chose this approach over alternative methods (random regret minimization, for example) because of its proven consistency in explaining choice behavior in health applications. We assumed that individual i(i = 1,.,N) makes choices such that they maximize utility over the 4 alternatives presented (j = 1,2,3,4). Their axiomatic utility function U ij was decomposed into an explainable systematic component V ij and a random component e ij , and we specified an indirect utility function for the utility of respondent i from choice j in choice set c as the linear combination of attributes and an error term:
With V ijc the utility derived from a choice, X 9 ijc b the component of utility that is captured by DCE attributes, and e ijc a stochastic (random) component of utility. We specified the vector X ijc as the set of product attributes:
Where Product j , HIV j , Contraception j , STI j , Frequency j , and SideEffects j are the design attributes of the DCE, and b 0 a constant. We first estimated equation (1) using a multinomial (or conditional) logit model (MNL), which estimates the probability of individual i choosing alternative j among the set of options c as a probabilistic function of design attributes:
Although described as the workhorse of discrete choice modeling, the MNL requires 2 restrictive assumptions: the IIA assumption of independence of irrelevant alternatives (concordant with the IID distribution of the disturbance), and homogenous preferences across individuals, where every individual is assumed to have the same tastes as the sample average, which does not allow us to uncover differences in preferences that are important in guiding policy. 18 We assumed that individuals choose the service associated with the highest utility, such that the probability that individual i chooses alternative j over k is given as:
In this paper, as different MNL models were estimated for each population, the assumption required was homogeneity of preferences within each group. As groups were more homogenous in nature due to separate inclusion criteria, assuming identical preferences across members within each group may have been less restrictive than assuming this across the range of populations in our sample. Nevertheless, to recognize that individuals within groups may have different preferences, we applied a random parameter logit (MMNL or mixed logit random parameter) model. The MMNL allows for preference (taste) heterogeneity within groups, so does not require the IIA assumption to hold. Briefly, the MMNL extends the MNL model by decomposing the error term into 2 components:
which, when the distribution of the random component G ij is specified by the analyst, is used to estimate individual-level coefficients:
where d k Z reflects observable heterogeneity, and G k v ik unobservable heterogeneity. Finally, we used a latent class approach to explore unobserved heterogeneity in choice data. A semi-parametric approach, a latent class model assumes the existence of underlying subgroups (classes) of respondents whose membership of each class is characterized by unobserved, or latent, variables. A posterior probability was assigned to each participant for membership to each class, and when participants were allocated to classes based on their highest probability, it was possible to compare the observable characteristics of participants across classes. 18, 34 Latent class modeling offers a different approach to relaxing the IIA assumption of the MNL model. Furthermore, the basic latent class model does not require parametric distributional assumptions to be imposed by the analyst, while the results are less sensitive to computational variations in estimation, such as starting values or optimization algorithms, which can vary across software packages. 35, 36 A latent class approach estimates separate parameter vectors for different classes of the sample with MNL models. The model relaxes the IIA assumption by assuming that preferences are homogenous within, but not across, classes. Thus, the probability of respondent i choosing alternative j in choice set c conditional on class membership k is:
The probability of respondent i belonging to class k is p ik . Class membership was unobservable; however, we could regress the probability of class membership on a set of observable characteristics, such that:
with Z i a vector of individual characteristics, and d k a vector of parameters to be estimated. We ran latent class logit models on the male sample, alongside a pooled sample of all 3 female groups. This approach removed the implicit assumption that women's preferences will differ by their sample category, and instead allowed the data to drive evidence of variation and similarity among subgroups. By pooling, we lost generalizability from the results of this specification; however, the results from the pooled analysis were useful to identify important subgroups of the female population. We assessed the optimal number of classes through comparison of model fit via log-likelihood function and Akaike Information Criteria (AIC).
Heterogeneity
We used 2 approaches to explore heterogeneity in preferences. First, we examined the distribution parameters of the MMNL model to see where variation remains in addition to that captured by the random parameters. Second, we estimated the latent class model (equation 8) and explored how preferences vary by class, specifying several observable characteristics (Appendix Table S1 ), which influence the probability of class membership.
Our rationale for including these observable characteristics is as follows. Age is strongly associated with HIV and pregnancy risk; 37 ,38 yet, little is known about the effect of age on preferences for protection against HIV or pregnancy. Structural drivers are legal, economic, and social factors that shape HIV risk. 39 Exposure to intimate partner violence (IPV) has been shown to be associated with increased HIV risk in many contexts, 40, 41 whereas limited livelihood opportunities and unrestricted alcohol availability alongside drinking norms are also significant factors in HIV risk. [42] [43] [44] [45] Finally, life circumstances play an important role in the extent to which people place themselves at, or are able to protect themselves from, HIV risk. 46, 47 We therefore explored attitudes towards pregnancy among women and how preferences may be affected by male circumcision, which reduces the likelihood of a male acquiring HIV. 48, 49 Finally, we explored associations with protective attributes, having an external partner in the previous 3 months, and having high HIV knowledge as assessed by the number of correct answers on a knowledge tool. 50 
Model Estimation
Models were estimated in NLOGIT 5 51 through a maximum likelihood approach and MMNL models were estimated using 500 Halton draws with start values obtained from a MNL model. All parameters were generic across 3 unlabeled alternatives, with labels entering the DCE through an attribute level. All design attributes were specified as random, with parameters following a normal distribution to characterize our uncertainty in the nature and direction of heterogeneity around coefficients. Triangular and lognormal distributions were tested and did not change the sign or significance of the main effects. General population samples were analyzed with survey weighting such that age and sex characteristics matched those of the general population. FSW RDS data were weighted using age characteristics using RDSAT software. 52 All attribute levels were effects coded, except for HIV protection, which was estimated linearly. 53 (Effects coding is similar to dummy coding in that it allows for non-linear effects in attribute levels, but does not perfectly confound the base attribute level with the grand mean of the utility function. Coefficients are therefore interpreted as divergence from the mean for that attribute.)
Results
Sample Characteristics and Generalizability
In the household survey of 2,271 persons identified doorto-door, 650 were eligible (29%). Of those, 30 (5%) were not found after 5 attempts and 11 (2%) refused to be interviewed, leading to 609 (94%) completed interviews. In total, 661 interviewees met the DCE eligibility criteria across the 4 populations. Notably, 126 (62%) adolescent girls reported not being sexually active, and self-reported HIV prevalence was broadly comparable across and within populations to that of other representative surveys. 3, 4 The inclusion criteria for adolescent girls did not require sexual activity, because adolescent girls face substantial and immediate risk of HIV at sexual debut, and HIV prevention programs do not target based on reported sexual activity. The preferences of non-sexually active adolescents are important for ensuring that attractive products are made available at the earliest possible exposure to HIV risk. In addition, if sexual activity was an explicit inclusion criterion for adolescents, confidentiality could have been breached if other members of the household knew that an interview did, or did not, take place. Table 2 displays the descriptive statistics for eligible respondents in each population. Comparability is limited across groups due to varying inclusion criteria for adolescent girls and FSWs, the latter also sampled through RDS. The mean age across adult groups was similar and while many respondents in each group reported being in a relationship, few reported cohabiting with a sexual partner. Reported lifetime sexual partners among adult males (13.06 partners) were higher than among adult females (4.55). Reported condom use at last sex with a regular partner was significantly lower among adult females (43%) than any other group; although, this figure is comparable with that of 34% from a nationally representative survey. 3, 4 The DCE was well understood by participants; just 2% of respondents reported finding the DCE quite difficult or very difficult, and 81% of respondents chose the same alternative twice in the repeated choice task. Sixtyone percent of respondents chose the product (or one of the products when values were duplicated) with the highest HIV protection in every choice set. Table 3 shows MMNL results and reports the coefficients of each attribute level parameter. Results from the MNL model are given in Appendix Table S2 . Where coefficients are significantly greater than zero, an attribute can be interpreted as having a relatively positive impact on participant utility. The magnitude of coefficients can be directly compared within each model. The significance of coefficients (i.e., what is important to people's choices) can be compared across populations but, due to possible differences in the scale of choice data across groups, coefficients cannot be directly compared across populations. In both specifications and across all groups, HIV protection was the strongest determinant of choice, whereas protection against pregnancy and other STIs was also significantly attractive. The absence of side-effects was important to adult men but not to any female groups; although FSWs found nausea significantly worse than other side-effects. There was no clear pattern of demand around frequency of use across groups.
Analysis of Preference Data
There are some differences between the product coefficients in the MNL and MMNL models, indicating that tastes vary within populations; this is also highlighted by the positive distribution parameters. In both specifications, adult women and FSWs significantly dislike oral PrEP and favor injectable products, with FSWs additionally disliking microbicide gels. Among adolescent girls, the MNL indicates a significant dislike for the vaginal ring, which is insignificant in the MMNL model, whereas the MMNL model shows the same pattern of statistically significant preferences for oral PrEP and injectable products as other female groups.
Preference Heterogeneity
Latent class specification. Latent class models are presented for female and male respondents in panels A and B of Table 4 , respectively, and were computed without survey weighting. HIV knowledge (as assessed through the tool presented in Appendix Material 1) is a key driver of demand for HIV protection, as Class 1 members (34% of the female sample) showed strong preferences for STI and pregnancy protection but do not value HIV protection in a new product. Class membership is additionally predicted by being of younger age, a FSW, or an adolescent, indicating that there is significant variation in preferences among female groups. A HIV preventive MPT would offer substantial benefit to this group of women, as contraceptive or STI preventative products could be bundled with HIV protection, offering additional protection.
In contrast, members of class 2 (19% of the sample) displayed very strong preferences for HIV protection, valuing it more than twice as highly as other classes. Class 2 members also value pregnancy protection but did not find STI protection appealing. Class 2 appears to be a high-risk group as, relative to class 3, members were more likely to have used alcohol the last time they had sex, and have lower HIV knowledge. Finally, class 2 members were more likely to be FSW or adolescent girls than class 3 members, and indicate a dislike for coitally specific products. Class 3 members (48% of the sample) strongly valued protection from HIV, pregnancy, and STIs, and indicate a dislike for the vaginal ring product. This group is likely to comprise of adult women in the general population.
Among adult males, membership of either class (42%) was not significantly predicted by the characteristics we defined, indicating that drivers of preference heterogeneity differ between men and women and that male preferences are not shaped by structural risks in the same manner as female preferences. However, there was still evidence of heterogeneity in preferences among adult men. The most notable variation between the 2 groups was the non-significance of the pregnancy prevention parameter among class 2 men. This suggested that, to make HIV prevention products attractive to these men, potential HIV and STI prevention properties should be emphasized. Men in class 1 strongly preferred oral PrEP, whereas the strongly significant opt-out parameters in both groups showed an inclination to continue current practice; this suggested that the expected reporting bias towards switching to new products may not be as strong as hypothesized.
Marginal effects. DCEs estimate the relative strength of preferences, and therefore we cannot simply compare the magnitude of coefficients across groups. However, the ratios of coefficients are comparable across populations and show the variation in trade-offs across groups. The marginal effects of factors relative to the common denominator of HIV protection are provided in Appendix Table S3 , computed from the coefficients in Table 3 . Adult men were only willing to forgo 3% HIV protection for a contraceptive product but adult women were willing to forgo 11%. Results suggest that all female groups value the male condom substantially more than men, and that preferences for STI protection are broadly comparable to pregnancy protection across female groups. Men value the absence of side-effects much more than women, and FSWs value STI protection almost 3 times greater than any other group.
Discussion
This study assessed preferences for new HIV prevention products among adult men and women, adolescent girls, and female sex workers. Consistent with prior expectations, HIV protection was the most important attribute Significance at 10% (a); 5% (b); 1% (c) level. Models for each population analyzed separately, and indicated as significant if different from zero.
to respondents, particularly those with high levels of HIV knowledge. However, the results suggest that demand would increase for all groups if multipurpose protection was incorporated. There was relatively little variation in preferences for oral PrEP, microbicide gel, the SILCS diaphragm, and the vaginal ring when compared to strong preferences for a long-lasting injectable ARV. This could be influenced by the strong awareness and use of injectable contraceptives in South Africa. 54 This study also provides evidence to explain data from clinical trials of new HIV prevention products. Neither adult women nor adolescent girls found the vaginal ring appealing but an injectable product was favored by all groups. In the context of trial data suggesting that younger women were not able to adhere to vaginal ring use to the same extent as older women, 8, 9 these results suggest that younger women do not favor a vaginal ring prevention system. Incorporating multipurpose properties to a vaginal ring could mitigate some of the intrinsic dislike of this product; however, these data suggest that a vaginal ring product will not be an attractive offering for younger populations.
Importantly, this study suggests that, to fully catch the attention of AGYW, products must not be Significance at 10% (a), 5% (b), 1% (c) level. Models for each population analyzed separately, and indicated as significant if different from zero. Standard errors not retrievable in latent class specification for base categories ''SILCS diaphragm,'' ''Injectable,'' ''Annually,'' and ''No side-effects.'' single-purpose but provided to offer multipurpose prevention against HIV, pregnancy, and other STIs. AGYW have been identified as key populations in HIV prevention, and it is critical that new biomedical products are made to be attractive and easy for these women to use. 3 Although MPT products are generally at the concept stage of development, bundling PrEP with other sexual and reproductive health services may make it more attractive than vertical programs until an MPT is licensed.
Although there are some similarities across the groups, the divergence in preferences shown here can provide useful information for programming. Adolescent and adult females are unlikely to be put off by minor side-effects and demonstrate comparable, statistically significant preferences for STI and pregnancy protection. Adult women, however, are much more likely to find the male condom appealing relative to newer products, indicating that demand for ARV-based prevention may be less among older, lower-risk women who may prefer ondemand methods. Products rolled out into higher-risk groups (such as AGYW) are more likely to be costeffective, as long as they can be used consistently and effectively. 55 Findings from the latent class analysis showed notable segments in the market for PrEP, with some women very concerned about HIV and STI protection, and others who are not at all. In addition, FSWs demonstrated a much stronger preference for STI protection than any other group, perhaps because STI acquisition is more likely to immediately affect their earnings than HIV or pregnancy. 56 Finally, these results suggest that a one size-fits all HIV prevention package will not be an effective or efficient use of resources. This is consistent with recent trajectories of contraceptive and HIV research where it has been recognized that a range of options can optimize uptake and adherence. 57 Because groups have different preferences and needs, further highlighted by these results, there is a strong case for greater tailoring of prevention services, particularly for at-risk young women.
This study has some limitations. First, DCEs are hypothetical tools and may not correlate perfectly with real-world choices. However, recent evidence shows that DCEs conducted in health fields predict real-world choices with a relatively high sensitivity, suggesting a reasonable degree of external validity. 58 Overall, the random sample of the general population survey design and the similarity of sample descriptive statistics with other representative surveys mean that our findings may have relevance for other South African settings. Self-reported rates of condom use among males and adolescent girls were higher than those in other representative surveys and may indicate acceptability biases in reporting, or that condoms were more readily available to this group than others. This study did not include a price attribute, and therefore does not enable the calculation of willingnessto-pay estimates for different products. However, given the South African context, where prevention products will likely be free-of-charge to potential users in the public sector, the inclusion of a price element would have made the choice task unrealistic.
Product profiles in the DCE do not perfectly match with candidate products in development; for example, injectable trials are based on administration every 8 weeks rather than every 4 or 12 weeks, as explored in this DCE. Likewise, rare but serious side-effects were not included in the choice tasks. In addition, injectable products may be more likely to initiate drug resistance, as they remain in the body at a low level 59 , and this is not included here. Finally, there is a lively literature discussing the reliability of RDS to generate generalizable samples, suggesting that, at worst, RDS is a superior form of convenience sampling for hard-to-reach populations and, at best, produces bias-free and generalizable samples. 32, 60 Further research is needed to estimate the impact and cost-effectiveness of potential single-and multi-purpose HIV prevention products. If models do not incorporate the variation in product preferences that we observed here and, instead, assume an average uptake across groups, they may give misleading results. Because models are used to generate impact predictions for investment cases in low-and middle-income countries (e.g., in South Africa 61 ), inaccurate predictions could result in reduced efficiency in the allocation of resources, and large opportunity costs in terms of benefits forgone. This paper shows that attention should be paid to the perspectives of different groups of end-users.
This study involved a DCE among 4 groups in Ekurhuleni Municipality in South Africa. In general, respondents indicated a strong desire for products that are highly effective in preventing HIV infection. However, there was strong demand across all groups for multipurpose prevention products to protect against other STIs and pregnancy. Further analysis shows substantive heterogeneity across and within groups, suggesting that a variety of prevention methodologies are required to meet the demands of different groups. These results strengthen the call for effective and attractive multipurpose prevention technologies to be deployed as part of a comprehensive combination prevention strategy.
